The U.S. FDA approved Merck & Co. Inc.’s Keytruda Qlex (pembrolizumab and berahyaluronidase alfa-pmph) injection on Sept. 19, making it the first and only subcutaneously (SC)-administered immune ...
After receiving an injection, some people experience symptoms at the injection site on the skin. This reaction is a common adverse effect of vaccines, Botox injections, biologics, and chemotherapy.
The Chosun Ilbo on MSN
In vivo CAR-T offers single-injection cancer treatment hope
Will a world where cancer is treated with a single injection arrive? The so-called ‘in vivo CAR-T’ method, which directly alters immune cells within the body, is recently transforming the cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results